Lead Product(s) : XVR011
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I/ Phase II
Sponsor : ExeVir Bio
Deal Size : Undisclosed
Deal Type : Collaboration
ExeVir and Mithra Announce Manufacturing Collaboration for Innovative Covid-19 Treatments
Details : XVR011 is a single domain-based anti-SARS-CoV-2 antibody (llama-derived VHH-Fc) optimized for stability, safety, broad neutralizing capability and excellent manufacturability.
Product Name : XVR011
Product Type : Antibody
Upfront Cash : Undisclosed
July 15, 2021
Lead Product(s) : XVR011
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : ExeVir Bio
Deal Size : Undisclosed
Deal Type : Collaboration